The Impact of (the Concept of) Treatment-Resistant Depression: An Opinion Review
Open accessThe DOI matches its Crossref record; 75 of the 75 references it cites were found in a registry or an index.
Abstract
Treatment-resistant depression refers to major depressive disorder, treatment of the disorder, and failure to obtain an "acceptable" outcome. Regarding the disorder, the heterogeneous concept of major depressive disorder and the multiple definitions of treatment-resistant depression, hesitating between a categorical and a more dimensional approach, as well as the divergence between diagnostic criteria and the items in the assessment scales are a source of confusion. Classifications do not take into account the dramatic influence of patient characteristics strongly impacting outcome, although these can be the cause of so-called pseudo-resistance. Outcome is the result of spontaneous evolution, nonspecific factors (including placebo), and active treatment factors. These should be differentiated to have a reliable estimation of the impact of different treatment modalities before we can asses treatment-resistant depression or before we can ascertain the (non)efficacy of treatments for treatment-resistant depression.The impact and burden of major depressive disorder and treatment-resistant depression are immense and go far beyond their economic cost. It is often forgotten that both are not only associated with increased suicidality but also with nonsuicidal mortality and that both can even result in requests for assisted dying. The caregiver burden and associated stigma are also too often overlooked despite that it has been suggested that they do influence (treatment) outcome.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“None of the extant TRD definitions are universally accepted and/or implemented at point- of- care in clinical practice 11,32,64- 68 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [64]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“The foregoing cascade approach - which in tegrates aspects of misdiagnosis, non- ad herence, inadequate treatment trials, as well as implementation gaps - underscores the high prevalence of poor outcomes of depression in primary care, of which a significant percentage would be expected to meet crite ria for TRD 10,30,64,71,107,108 .”
From Treatment‐resistant depression: definition, prevalence, detection, management, and investigational interventions (2023) · cites this paper as [64]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Diagnostic and Statistical Manual of Mental Disorders
American Psychiatric Association (2013) · doi:10.1176/appi.books.9780890425596 · Cited by 116,369
Diagnostic and Statistical Manual of Mental Disorders
Williams, J. B. W., & First, M. (2013) · Encyclopedia of Social Work · doi:10.1093/acrefore/9780199975839.013.104 · Cited by 109,519
Molecular Mechanisms of Depression: Perspectives on New Treatment Strategies
Lang, U. E., & Borgwardt, S. (2013) · Cellular Physiology and Biochemistry · doi:10.1159/000350094 · Cited by 8,475
Scoville, W. B. (1949) · Journal of neurosurgery · doi:10.3171/jns.1949.6.1.0065 · Cited by 7,380
Frank, E. (1991) · Archives of General Psychiatry · doi:10.1001/archpsyc.1991.01810330075011 · Cited by 1,959 · cited 1×
“The standard definition of response and remission is 50% improvement from baseline and 3 weeks with virtual absence of depressive symptoms, respectively (Frank et al., 1991).”
BackgroundThe Economic Burden of Adults With Major Depressive Disorder in the United States (2005 and 2010)
Greenberg, P. E., Fournier, A.-A., Sisitsky, T., Pike, C. T., & Kessler, R. C. (2015) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.14m09298 · Cited by 1,779
The economic cost of brain disorders in Europe
Olesen, J., Gustavsson, A., Svensson, M., Wittchen, H. ‐., Jönsson, B., on behalf of the CDBE2010 study group, & the European Brain Council (2012) · European Journal of Neurology · doi:10.1111/j.1468-1331.2011.03590.x · Cited by 1,481
Fried, E. I., & Nesse, R. M. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.10.010 · Cited by 1,043
van Melle, J. P., de Jonge, P., Spijkerman, T. A., Tijssen, J. G. P., Ormel, J., van Veldhuisen, D. J., van den Brink, R. H. S., & van den Berg, M. P. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000146294.82810.9c · Cited by 1,034
The inventory for depressive symptomatology (IDS): Preliminary findings
John Rush, A., Giles, D. E., Schlesser, M. A., Fulton, C. L., Weissenburger, J., & Burns, C. (1986) · Psychiatry Research · doi:10.1016/0165-1781(86)90060-0 · Cited by 918
Affective disorders and suicide risk: a reexamination
Bostwick, J. M., & Pankratz, V. S. (2000) · American Journal of Psychiatry · doi:10.1176/appi.ajp.157.12.1925 · Cited by 878
Lawrence, D., Hancock, K. J., & Kisely, S. (2013) · BMJ · doi:10.1136/bmj.f2539 · Cited by 819 · cited 1×
“Although suicide risk receives much attention, the largest part of excess mortality is due to physical illnesses, including cardiovascular disease, respiratory disease, and cancer (Lawrence et al., 2013).”
BackgroundNeurobiological Mechanisms of the Placebo Effect
Benedetti, F., Mayberg, H. S., Wager, T. D., Stohler, C. S., & Zubieta, J.-K. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3458-05.2005 · Cited by 777
The STAR*D project results: A comprehensive review of findings
Warden, D., Rush, A. J., Trivedi, M. H., Fava, M., & Wisniewski, S. R. (2007) · Current Psychiatry Reports · doi:10.1007/s11920-007-0061-3 · Cited by 727
The Functional Neuroanatomy of the Placebo Effect
Mayberg, H. S., Silva, J. A., Brannan, S. K., Tekell, J. L., Mahurin, R. K., McGinnis, S., & Jerabek, P. A. (2002) · American Journal of Psychiatry · doi:10.1176/appi.ajp.159.5.728 · Cited by 720
Nelson, J. C., & Papakostas, G. I. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2009.09030312 · Cited by 552
Souery, D., Oswald, P., Massat, I., Bailer, U., Bollen, J., Demyttenaere, K., Kasper, S., Lecrubier, Y., Montgomery, S., Serretti, A., et al. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0713 · Cited by 521
Self-citationMarcus, R. N., McQuade, R. D., Carson, W. H., Hennicken, D., Fava, M., Simon, J. S., Trivedi, M. H., Thase, M. E., & Berman, R. M. (2008) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0b013e31816774f9 · Cited by 518
Relationship of neurotransmitters to the symptoms of major depressive disorder.
Nutt, D. (2008) · PubMed · Cited by 490
Treatment-Resistant Depression
(2015) · Encyclopedia of Psychopharmacology · doi:10.1007/978-3-642-36172-2_200431 · Cited by 488
Hypericum Depression Trial Study Group (2002) · JAMA · doi:10.1001/jama.287.14.1807 · Cited by 480
(2007) · PubMed · Cited by 453
Psychiatric Illness and Family Stigma
Phelan, J. C., Bromet, E. J., & Link, B. G. (1998) · Schizophrenia Bulletin · doi:10.1093/oxfordjournals.schbul.a033304 · Cited by 445
Berman, R. M., Marcus, R. N., Swanink, R., McQuade, R. D., Carson, W. H., Corey-Lisle, P. K., & Khan, A. (2007) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v68n0604 · Cited by 409
The Sequenced Treatment Alternatives to Relieve Depression (STAR*D) Trial: A Review
Sinyor, M., Schaffer, A., & Levitt, A. (2010) · The Canadian Journal of Psychiatry · doi:10.1177/070674371005500303 · Cited by 396
The Impact of Treatment-Resistant Depression on Health Care Utilization and Costs
Crown, W. H., Finkelstein, S., Berndt, E. R., Ling, D., Poret, A. W., Rush, A. J., & Russell, J. M. (2002) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.v63n1102 · Cited by 386
Mechanisms of Placebo and Placebo-Related Effects Across Diseases and Treatments
Benedetti, F. (2008) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.48.113006.094711 · Cited by 385
Papakostas, G. I., & Fava, M. (2009) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2008.08.009 · Cited by 382
Estimating remission from untreated major depression: a systematic review and meta-analysis
Whiteford, H. A., Harris, M. G., McKeon, G., Baxter, A., Pennell, C., Barendregt, J. J., & Wang, J. (2013) · Psychological Medicine · doi:10.1017/s0033291712001717 · Cited by 375 · cited 1×
“Spontaneous remission in untreated major depression was found to be 23%, 32%, and 53% after 3, 6, and 12 months, respectively, although lower figures were observed in more severely depressed patient (Whiteford et al., 2013).”
BackgroundThe heterogeneity of “major depression”
GOLDBERG, D. (2011) · World Psychiatry · doi:10.1002/j.2051-5545.2011.tb00061.x · Cited by 335 · cited 1×
“It does seem, as Goldberg (2011) put it, that considering all these types of MDD as a single mental disorder is close to “magical thinking.””
BackgroundStruening, E. L., Perlick, D. A., Link, B. G., Hellman, F., Herman, D., & Sirey, J. A. (2001) · Psychiatric Services · doi:10.1176/appi.ps.52.12.1633 · Cited by 332
Kim, S. Y. H., De Vries, R. G., & Peteet, J. R. (2016) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2015.2887 · Cited by 320
Carney, R. M., Blumenthal, J. A., Freedland, K. E., Youngblood, M., Veith, R. C., Burg, M. M., Cornell, C., Saab, P. G., Kaufmann, P. G., Czajkowski, S. M., et al. (2004) · Psychosomatic Medicine · doi:10.1097/01.psy.0000133362.75075.a6 · Cited by 291
Berman, R. M., Fava, M., Thase, M. E., Trivedi, M. H., Swanink, R., McQuade, R. D., Carson, W. H., Adson, D., Taylor, L., Hazel, J., et al. (2009) · CNS Spectrums · doi:10.1017/s1092852900020216 · Cited by 260
Conway, C. R., George, M. S., & Sackeim, H. A. (2017) · JAMA Psychiatry · doi:10.1001/jamapsychiatry.2016.2586 · Cited by 244
Fonagy, P., Rost, F., Carlyle, J., McPherson, S., Thomas, R., Pasco Fearon, R. M., Goldberg, D., & Taylor, D. (2015) · World Psychiatry · doi:10.1002/wps.20267 · Cited by 237
Thienpont, L., Verhofstadt, M., Van Loon, T., Distelmans, W., Audenaert, K., & De Deyn, P. P. (2015) · BMJ Open · doi:10.1136/bmjopen-2014-007454 · Cited by 231
Treatment-resistant depression
Souery, D., Papakostas, G. I., & Trivedi, M. H. (2006) · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · Cited by 231
Treatment-Resistant Depression: Response to Low-Dose Transdermal But Not Oral Selegiline
Morgan, P. T. (2007) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000270085.15253.15 · Cited by 222
Glassman, A. H., Bigger, J. T., & Gaffney, M. (2009) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2009.121 · Cited by 215
Kwan, B. M., Dimidjian, S., & Rizvi, S. L. (2010) · Behaviour Research and Therapy · doi:10.1016/j.brat.2010.04.003 · Cited by 214
Staging methods for treatment resistant depression. A systematic review
Ruhé, H. G., van Rooijen, G., Spijker, J., Peeters, F. P. M. L., & Schene, A. H. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.02.020 · Cited by 210
Perceived stigma and depression among caregivers of patients with bipolar disorder
Perlick, D. A., Miklowitz, D. J., Link, B. G., Struening, E., Kaczynski, R., Gonzalez, J., Manning, L. N., Wolff, N., & Rosenheck, R. A. (2007) · British Journal of Psychiatry · doi:10.1192/bjp.bp.105.020826 · Cited by 190
Family caregiving in depression: impact on caregivers' daily life, distress, and help seeking
van Wijngaarden, B., Schene, A. H., & Koeter, M. W. J. (2004) · Journal of Affective Disorders · doi:10.1016/s0165-0327(03)00168-x · Cited by 177
The economic burden of depression in the US: societal and patient perspectives
Greenberg, P. E., & Birnbaum, H. G. (2005) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.6.3.369 · Cited by 166 · cited 1×
“5% between 2005 and 2010 (from 173 to 210 billion dollar); 45% of that cost was due to direct costs, 5% to suicide related costs and 55% to indirect costs (Greenberg and Birnbaum, 2005; Greenberg et al., 2015).”
BackgroundTreatment-Resistant Depression and Mortality After Acute Coronary Syndrome
Carney, R. M., & Freedland, K. E. (2009) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2008.08081239 · Cited by 163 · cited 1×
“Although current evidence does not seem univocally conclusive on the effect of treatment intervention on morbidity and mortality (Carney and Freedland, 2009), research does show that the risk of cardiovascular morbidity and mortality is higher in patients who are non-responsive to treatment.”
Background(2010) · PubMed · Cited by 157
de Jonge, P., Honig, A., van Melle, J. P., Schene, A. H., Kuyper, A. M. G., Tulner, D. M., Schins, A., Ormel, J., & The MIND-IT Investigators (2007) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2007.06091492 · Cited by 150
Treatment-Resistant Depression in Primary Care across Canada
Rizvi, S. J., Grima, E., Tan, M., Rotzinger, S., Lin, P., McIntyre, R. S., & Kennedy, S. H. (2014) · The Canadian Journal of Psychiatry · doi:10.1177/070674371405900702 · Cited by 144 · cited 1×
“7% (12% to 28% depending on the geographical region) (Rizvi et al., 2014).”
BackgroundKubitz, N., Mehra, M., Potluri, R. C., Garg, N., & Cossrow, N. (2013) · PLoS ONE · doi:10.1371/journal.pone.0076882 · Cited by 143
Recovery After 5 Years of Unremitting Major Depressive Disorder
Mueller, T. I. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830090040006 · Cited by 127
Fekadu, A., Wooderson, S. C., Markopoulou, K., & Cleare, A. J. (2009) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.08m04728 · Cited by 125
Empirical Testing of Two Models for Staging Antidepressant Treatment Resistance
Petersen, T., Papakostas, G. I., Posternak, M. A., Kant, A., Guyker, W. M., Iosifescu, D. V., Yeung, A. S., Nierenberg, A. A., & Fava, M. (2005) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000169036.40755.16 · Cited by 110
Viola, S., & Moncrieff, J. (2016) · BJPsych Open · doi:10.1192/bjpo.bp.115.002246 · Cited by 101
Treatment-resistant major depressive disorder and assisted dying
Schuklenk, U., & Vathorst, S. V. D. (2015) · Journal of Medical Ethics · doi:10.1136/medethics-2014-102458 · Cited by 93
Gale, C. R., Batty, G. D., Osborn, D. P. J., Tynelius, P., Whitley, E., & Rasmussen, F. (2012) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2011.2000 · Cited by 79
Augmentation strategies for treatment-resistant depression
Carvalho, A. F., Machado, J. R., & Cavalcante, J. L. (2009) · Current Opinion in Psychiatry · doi:10.1097/yco.0b013e32831be9ef · Cited by 78
Prediction of longer-term outcome of treatment-resistant depression in tertiary care
Fekadu, A., Rane, L. J., Wooderson, S. C., Markopoulou, K., Poon, L., & Cleare, A. J. (2012) · British Journal of Psychiatry · doi:10.1192/bjp.bp.111.102665 · Cited by 77
Scherrer, J. F., Chrusciel, T., Garfield, L. D., Freedland, K. E., Carney, R. M., Hauptman, P. J., Bucholz, K. K., Owen, R. R., & Lustman, P. J. (2012) · The British Journal of Psychiatry · doi:10.1192/bjp.bp.111.096479 · Cited by 73
Olin, B., Jayewardene, A. K., Bunker, M. T., & Moreno, F. (2012) · PLoS ONE · doi:10.1371/journal.pone.0048002 · Cited by 68
Chen, J. A., Papakostas, G. I., Youn, S. J., Baer, L., Clain, A. J., Fava, M., & Mischoulon, D. (2011) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.10m06453 · Cited by 56
Physician-assisted suicide and psychiatric illness
Vandenberghe, J. (2018) · New England Journal of Medicine · doi:10.1056/nejmp1714496 · Cited by 50 · cited 1×
“Moreover, it seems extremely difficult to evaluate “rational suicidality” or “a rational request for physicianassisted suicide in depression (Vandenberghe, 2018).”
BackgroundTreatment‐Resistant Depression and Risk of Suicide
Pfeiffer, P. N., Kim, H. M., Ganoczy, D. A., Zivin, K., & Valenstein, M. M. (2013) · Suicide and Life-Threatening Behavior · doi:10.1111/sltb.12022 · Cited by 37
Gostin, L. O., & Roberts, A. E. (2016) · JAMA · doi:10.1001/jama.2015.16586 · Cited by 30
Effective treatment of depression improves post-myocardial infarction survival
Banankhah, S. K., Friedmann, E., & Thomas, S. (2015) · World Journal of Cardiology · doi:10.4330/wjc.v7.i4.215 · Cited by 29
What is treatment resistance in psychiatry? A “difficult to treat” concept
Demyttenaere, K. (2019) · World Psychiatry · doi:10.1002/wps.20677 · Cited by 28
Self-citationDemyttenaere, K., Verhaeghen, A., Dantchev, N., Grassi, L. G., Montejo, A. L., David, P., Quail, D., Reed, C. C., Tylee, A. T., & Bauer, M. (2010) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.08m00748blu · Cited by 26
Self-citationTabeleão, V. P., Tomasi, E., & Quevedo, L. D. Á. (2017) · Community Mental Health Journal · doi:10.1007/s10597-017-0126-7 · Cited by 25
Psychological and physiological effects of caring for patients with treatment-resistant depression
Rane, L. J., Fekadu, A., Papadopoulos, A. S., Wooderson, S. C., Poon, L. C., Markopoulou, K., & Cleare, A. J. (2012) · Psychological Medicine · doi:10.1017/s0033291711003035 · Cited by 23
Identification and treatment of antidepressant tachyphylaxis.
Targum, S. D. (2014) · PubMed · Cited by 23
What is important in being cured from: Does discordance between physicians and patients matter? (2)
Demyttenaere, K., Donneau, A., Albert, A., Ansseau, M., Constant, E., & van Heeringen, K. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.12.002 · Cited by 21
Self-citationChen, J. A., Vijapura, S., Papakostas, G. I., Parkin, S. R., Kim, D. J. H., Cusin, C., Baer, L., Clain, A. J., D, M. F. M., & Mischoulon, D. (2014) · Asian Journal of Psychiatry · doi:10.1016/j.ajp.2014.12.002 · Cited by 20
Kampermann, L., Nestoriuc, Y., & Mora, M. C. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0178719 · Cited by 18
Demyttenaere, K., Reines, E. H., Lönn, S. L., & LADER, M. H. (2011) · The Primary Care Companion For CNS Disorders · doi:10.4088/pcc.10m01080 · Cited by 13
Self-citationEditorial for Treatment-Resistant Depression (TRD)
Kasper, S. F., & Frazer, A. (2019) · The International Journal of Neuropsychopharmacology · doi:10.1093/ijnp/pyz006 · Cited by 10
Research works printed but not linked: 1
- World Health Organization, 2017, Depression and other common mental disorders: global health estimates
Cited by
McIntyre, R. S., Alsuwaidan, M., Baune, B. T., Berk, M., Demyttenaere, K., Goldberg, J. F., Gorwood, P., Ho, R., Kasper, S., Kennedy, S. H., et al. (2023) · World Psychiatry · doi:10.1002/wps.21120 · Cited by 836
Self-citationSackeim, H. A., Aaronson, S. T., Bunker, M. T., Conway, C. R., Demitrack, M. A., George, M. S., Prudic, J., Thase, M. E., & Rush, A. J. (2019) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2019.03.021 · Cited by 109
Greenway, K. T., Garel, N., Jerome, L., & Feduccia, A. A. (2020) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2020.1772054 · Cited by 94
“ing treatments are generally considered effective [5], treatment-resistance is a common and increasing clinical phenomenon [6,7].”
BackgroundSheikhan, N. Y., Henderson, J. L., Halsall, T., Daley, M., Brownell, S., Shah, J. L., Iyer, S. N., & Hawke, L. D. (2023) · BMC Health Services Research · doi:10.1186/s12913-023-09075-6 · Cited by 83
Economic impact of treatment-resistant depression: A retrospective observational study
Pérez-Sola, V., Roca, M., Alonso, J., Gabilondo, A., Hernando, T., Sicras-Mainar, A., Sicras-Navarro, A., Herrera, B., & Vieta, E. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.036 · Cited by 55
Metadata
- Authors
- Demyttenaere, K., & Van Duppen, Z.
- Affiliations
- KU Leuven (BE)
- University Psychiatric Center KU Leuven, Campus Kortenberg
- Corresponding author
- Demyttenaere, Koen
- ORCID
- Demyttenaere, Koen
- Venue
- International Journal of Neuropsychopharmacology
- Publisher
- Oxford University Press (OUP)
- Published
- 2018-06-28
- Volume
- 22
- Issue
- 2
- Pages
- 85-92
- ISSN
- 1461-1457 (ISSN-L)
- 1469-5111
- PMC
- PMC6368367
- OpenAlex
- W2809990157
- Cited by
- 98
- References
- 75
- Citations by year
- 2026: 6 · 2025: 10 · 2024: 25 · 2023: 19 · 2022: 13 · 2021: 12 · 2020: 6 · 2019: 7
- FWCI
- 0.73
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The International Journal of Neuropsychopharmacology (publishedVersion, cc-by-nc)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Lirias (submittedVersion, cc-by-nc)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Health Sciences › Medicine › Psychiatry and Mental health › Electroconvulsive Therapy Studies
- Keywords
- treatment-resistant depression, major depressive disorder, diagnostic criteria, pseudoresistance, treatment outcomes, placebo effect, suicidality, assisted dying, caregiver burden, stigma
- MeSH terms
- Major Depressive Disorder, Humans, Cost of Illness, Depressive Disorder, Treatment-Resistant
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.